← Back
Data updated: Mar 10, 2026
GUERBET
Oncology
GUERBET is a specialty pharmaceutical company focused on Oncology. Key products include DOTAREM.
1954
Since
6
Drugs
-
Trials
7
Approved (2yr)
Key Drugs
Recent Activity
ELUCIREM 2026-02-20
Efficacy
ELUCIREM 2025-03-05
Labeling
DOTAREM 2025-03-05
Labeling
ELUCIREM 2024-08-14
Labeling
DOTAREM 2024-08-14
Labeling
ELUCIREM 2024-07-23
Labeling
DOTAREM 2024-07-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs Phase 3: 1 Phase 2: 1 Phase 1: 1
Pipeline Strength Pro
Loading...
Discontinued (3)
Company Info
- First Approval
- 1954-03-31
- Latest
- 2026-02-20
- Applications
- 5